Janne Backman
Chairman of the Board
Janne Backman is a senior Life Science executive with over 15 years of international experience across Europe, the US, and Latin America. He has held leading roles in both global corporations and start-ups, focusing on marketing, sales, business development, and organizational growth.
Since 2016, he has founded and run, J.F.B Consulting, which supporting Life Science companies with strategic commercial projects. Janne also manages J.F.B Invest, an investment brand with a focus on early-stage opportunities in Life Science and related sectors. He brings broad therapeutic expertise in a number of areas.
Bo Söderpalm
Board member
Bo Söderpalm, born 1959, is a board member in Sobrera Pharma since 2019. Söderpalm, M.D., Ph.D., is Professor and Chief physician at the Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy, University of Gothenburg. He is the Co-Founder of Sobrera Pharma. Söderpalm is an experienced senior researcher and clinician since 30 years and has performed several clinical studies in the area of alcohol abuse.
Elin Löf
Board member
Elin Löf, born in 1974, has more than 10 years of experience with product development from the pharmaceutical industry, across psychiatry and neurology portfolios. She currently holds a position as Director and Head of Medical Strategy and Communication Neurology at H Lundbeck A/S headquarters in Denmark. Löf further has experience with research in the area of Alcohol Use Disorder from the Sahlgrenska Academy, University of Gothenburg where she did her PhD and Postdoc.
James (Jim) Gamgort
Board member
James (Jim) Gamgort is currently Chief Commercial Officer and Managing Partner at Encompass Communications and Learning, Inc. and has extensive international experience in pharmaceutical commercialization and business development, with a particularly strong footprint in the U.S. market. He brings deep expertise in global commercial strategy, strategic partnerships, and market positioning.
Lars Hallmayer
Board member
Lars Hallmayer is Managing Director at Welding Group and has long-standing experience in pharmaceutical development, formulation, and generics-based businesses. He contributes strong industrial expertise, as well as proven experience in efficiently advancing development projects from early stage through to commercialization.
Andrea de Bejczy
Board alternate
Andrea de Bejczy, M.D., Ph.D., at the Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy, University of Gothenburg is the Co-Founder of Sobrera Pharma. She is an experienced researcher and clinician and has performed several clinical studies in the area of alcohol abuse.
Klementina Österberg
Board alternate
CEO of GU Ventures and chair of GOKAP. Expert at building new companies. Experienced board member in the life science sector including Ectin Research AB, Aprit Biotech AB, Cereno Scientific AB, Texray AB, OnDosis AB, Iscaff Pharma AB, OligoNova Accelerate AB and Toleranzia AB.